These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36243559)

  • 41. A cross-country qualitative study on contraceptive method mix: contraceptive decisionmaking among youth.
    Ouma L; Bozkurt B; Chanley J; Power C; Kakonge R; Adeyemi OC; Kudekallu RJ; Leahy Madsen E
    Reprod Health; 2021 May; 18(1):105. PubMed ID: 34034757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contraceptive self-injection through routine service delivery: Health worker perspectives from Uganda.
    Morozoff C; Cover J; Namagembe A; Nsangi D; Komunyena Tumusiime J; Stout A; Kidwell Drake J
    Front Glob Womens Health; 2022; 3():890017. PubMed ID: 36204255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
    Polaneczky M; Liblanc M
    J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preference for Sayana® Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial.
    Polis CB; Nakigozi GF; Nakawooya H; Mondo G; Makumbi F; Gray RH;
    Contraception; 2014 May; 89(5):385-95. PubMed ID: 24332432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Introduction of Community-Based Provision of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in Benin: Programmatic Results.
    Okegbe T; Affo J; Djihoun F; Zannou A; Hounyo O; Ahounou G; Bangbola KA; Harris N
    Glob Health Sci Pract; 2019 Jun; 7(2):228-239. PubMed ID: 31171559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathways to increased coverage: an analysis of time trends in contraceptive need and use among adolescents and young women in Kenya, Rwanda, Tanzania, and Uganda.
    Dennis ML; Radovich E; Wong KLM; Owolabi O; Cavallaro FL; Mbizvo MT; Binagwaho A; Waiswa P; Lynch CA; Benova L
    Reprod Health; 2017 Oct; 14(1):130. PubMed ID: 29041936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Canadian Contraception Consensus (Part 2 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
    J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors associated with provision of depot medroxyprogesterone acetate to adolescents by US health care providers.
    Ermias Y; Morgan IA; Curtis KM; Whiteman MK; Horton LG; Zapata LB
    Contraception; 2019 May; 99(5):300-305. PubMed ID: 30763582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors affecting continuation rates of DMPA.
    Hubacher D; Goco N; Gonzalez B; Taylor D
    Contraception; 1999 Dec; 60(6):345-51. PubMed ID: 10715369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department.
    Potter LS; Dalberth BT; Cañamar R; Betz M
    Contraception; 1997 Nov; 56(5):305-12. PubMed ID: 9437559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Society of Family Planning committee consensus on self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC).
    Kohn JE; Berlan ED; Tang JH; Beasley A
    Contraception; 2022 Aug; 112():11-13. PubMed ID: 35378085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Self-administration with UniJect of the once-a-month injectable contraceptive Cyclofem.
    Bahamondes L; Marchi NM; Nakagava HM; de Melo ML; Cristofoletti Mde L; Pellini E; Scozzafave RH; Petta C
    Contraception; 1997 Nov; 56(5):301-4. PubMed ID: 9437558
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
    Polaneczky M; Guarnaccia M; Alon J; Wiley J
    Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A prospective cohort study to assess the acceptability of Sayana Press among 18-49-year-old women in Nepal.
    Sherpa LY; Tinkari BS; Gentle P; Sah RK; Shrestha A; Sahani SK; Aryal K; Ghimire J; Karki DK
    Contraception; 2021 Dec; 104(6):623-627. PubMed ID: 34280441
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pilot study of home self-administration of subcutaneous depo-medroxyprogesterone acetate for contraception.
    Cameron ST; Glasier A; Johnstone A
    Contraception; 2012 May; 85(5):458-64. PubMed ID: 22079602
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Barriers and facilitators adolescent females living with HIV face in accessing contraceptive services: a qualitative assessment of providers' perceptions in western Kenya.
    Hagey JM; Akama E; Ayieko J; Bukusi EA; Cohen CR; Patel RC
    J Int AIDS Soc; 2015; 18(1):20123. PubMed ID: 26385854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Would you offer contraception to a 14-year-old girl? Perspectives of health students and professionals in Dar es Salaam, Tanzania.
    Mwakawanga DL; Mkonyi E; Mushy SE; Trent M; Bonilla Z; Massae AF; Lukumay GG; Mgopa LR; Mohammed I; Wadley J; Ross MW; Leshabari S; Rosser BRS
    Reprod Health; 2021 Dec; 18(1):245. PubMed ID: 34895267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparative human rights analysis of laws and policies for adolescent contraception in Uganda and Kenya.
    Perehudoff K; Kibira D; Wuyts E; Pericas C; Omwoha J; van den Ham HA; Mantel-Teeuwisse AK; Michielsen K
    Reprod Health; 2022 Feb; 19(1):37. PubMed ID: 35130932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. What Distinguishes Women Who Choose to Self-Inject? A Prospective Cohort Study of Subcutaneous Depot Medroxyprogesterone Acetate Users in Ghana.
    Nai D; Tobey E; Fuseini K; Kuma-Aboagye P; Jain A
    Glob Health Sci Pract; 2022 Feb; 10(1):. PubMed ID: 35294390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.